BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Drug Development

  Cleveland Biolabs Inc. and Incuron Announce CBL0102 Orphan Drug Status for Hepatocellular Carcinoma

  October 2, 2012

   · 

  1 min read
• Drug Development

  Aduro Biotech Announces First Patient Enrolled in Mesothelioma Clinical Trial

  October 2, 2012

   · 

  1 min read
• BioCapital

  Akonni Biosystems Awarded $280,000 National Institutes of Health (NIH) Grant to Develop Benchtop Nucleic Acid Isolation Instrument

  October 2, 2012

   · 

  1 min read
• BrainLAB AG Introduces New Multi-Touch Surgical Information Hub

  October 2, 2012

   · 

  1 min read
• Drug Development

  TSI Initiates Phase 1 Study of New-Generation Thrombolytic, TS01

  October 2, 2012

   · 

  3 min read
• Pharm Country

  Welch Allyn’s New Ophthalmic Imaging Product Integrates Advanced Eye Exam Technology With iPhone™ Application

  October 2, 2012

   · 

  1 min read
• Pharm Country

  NeoStem, Inc. to Present at Multiple Conferences in October

  October 2, 2012

   · 

  1 min read
• Final Phase IIb Interferon-Free Hepatitis C Data From Boehringer Ingelheim Corporation to be Presented at AASLD

  October 2, 2012

   · 

  1 min read
• Drug Development

  Curis, Inc. Announces Dosing of First Patient in Phase I Clinical Trial of Oral Formulation of CUDC-101

  October 2, 2012

   · 

  1 min read
• Drug Development

  Athersys, Inc. Reports on Progress in Phase 2 Study of MultiStem for Ischemic Stroke

  October 2, 2012

   · 

  1 min read